BioCentury
ARTICLE | Financial News

RNA epigenetics company Accent raises $40M series A

May 18, 2018 7:08 PM UTC

RNA epigenetics company Accent Therapeutics Inc. (Lexington, Mass.) debuted with a $40 million series A co-led by The Column Group and Atlas Venture, with participation from EcoR1 Capital...

BCIQ Company Profiles

Accent Therapeutics Inc.